tiprankstipranks
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Technical Analysis

Compare
577 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Verve Therapeutics’s (VERV) Moving Averages Convergence Divergence (MACD) indicator is -0.39, suggesting Verve Therapeutics is a Buy.
Verve Therapeutics’s (VERV) 20-Day exponential moving average is 6.04, while Verve Therapeutics’s (VERV) share price is $5.4, making it a Sell.
Verve Therapeutics’s (VERV) 50-Day exponential moving average is 6.41, while Verve Therapeutics’s (VERV) share price is $5.4, making it a Sell.

Verve Therapeutics (VERV) Pivot Points

Mar 28, 2025, 06:39 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.62
4.96
5.18
5.53
5.75
6.09
6.31
Fibonacci
4.96
5.18
5.31
5.53
5.74
5.88
6.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verve Therapeutics (VERV) Moving Averages

Mar 28, 2025, 06:39 PM
Period
Simple
Exponential
MA5
5.57Sell
5.53Sell
MA10
5.73Sell
5.72Sell
MA20
6.03Sell
6.04Sell
MA50
6.89Sell
6.41Sell
MA100
6.37Sell
6.37Sell
MA200
5.99Sell
6.26Sell
Verve Therapeutics’s (VERV) 10-Day exponential moving average is 5.72, while Verve Therapeutics’s (VERV) share price is $5.4, making it a Sell.
Verve Therapeutics’s (VERV) 100-Day exponential moving average is 6.37, while Verve Therapeutics’s (VERV) share price is $5.4, making it a Sell.
Verve Therapeutics’s (VERV) stock price is $5.4 and Verve Therapeutics’s (VERV) 50-day simple moving average is 6.89, creating a Sell signal.
Verve Therapeutics’s (VERV) stock price is $5.4 and Verve Therapeutics’s (VERV) 100-day simple moving average is 6.37, creating a Sell signal.
Verve Therapeutics’s (VERV) stock price is $5.4 and Verve Therapeutics’s (VERV) 200-day simple moving average is 5.99, creating a Sell signal.

Verve Therapeutics (VERV) Technical Indicators

Mar 28, 2025, 06:39 PM
Name
Value
Implied Action
RSI (14)
36.30
Neutral
STOCH (9,6)
21.12
Neutral
STOCHRSI (14)
17.53
Buy
MACD (12,26)
-0.39
Buy
ADX (14)
20.18
Neutral
Williams %R
-93.85
Buy
CCI (14)
-162.23
Buy
ATR (14)
0.53
-
Ultimate Oscillator
49.20
Neutral
ROC
-21.31
Sell
Verve Therapeutics’s (VERV) Relative Strength Index (RSI) is 36.30, creating a Neutral signal.
Verve Therapeutics’s (VERV) Trend Strength Indicator (ADX) is 20.18, creating a Neutral signal.
Verve Therapeutics’s (VERV) Commodity Channel Index (CCI) is -162.23, creating a Buy signal.
Verve Therapeutics’s (VERV) Price Rate of Change (ROC) is -21.31, creating a Sell signal.

FAQ

Is VERV a Buy, Hold, or Sell?
Based on VERV’s technical indicators, VERV is a Sell.
    What is VERV’s RSI (14)?
    VERV’s RSI (14) is 36.30, which suggests VERV is a Neutral.
      What is VERV’s MACD?
      VERV’s MACD is -0.39, which suggests VERV is a Buy.
        What is VERV’s 5-day moving average?
        VERV’s 5-day moving average is 5.57, which suggests VERV is a Sell.
          What is VERV’s 20-day moving average?
          VERV 20-day moving average is 6.03, which suggests VERV is a Sell.
            What is VERV’s 50-day moving average?
            VERV’s 50-day moving average is 6.89, which suggests VERV is a Sell.
              What is VERV’s 200-day moving average?
              VERV’s 200-day moving average is 5.99, which suggests VERV is a Sell.
                What is VERV’s Williams % R (14)?
                VERV’s Williams % R (14) is -93.85, which suggests VERV is a Buy.
                  What is VERV’s CCI (14)?
                  VERV’s CCI (14) is -162.23, which suggests VERV is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis